Target Product Profiles for medical tests: a systematic review of current methods

被引:42
作者
Cocco, Paola [1 ]
Ayaz-Shah, Anam [2 ]
Messenger, Michael Paul [3 ,4 ]
West, Robert Michael [5 ]
Shinkins, Bethany [1 ,4 ]
机构
[1] Univ Leeds, Acad Unit Hlth Econ, Leeds Inst Hlth Sci, Test Evaluat Grp, Leeds, W Yorkshire, England
[2] Univ Leeds, Acad Unit Primary Care, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England
[3] Univ Leeds, Ctr Personalised Hlth & Med, Leeds, W Yorkshire, England
[4] NIHR Leeds In Vitro Diagnost IVD Cooperat, Leeds, W Yorkshire, England
[5] Univ Leeds, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England
基金
英国生物技术与生命科学研究理事会; 英国医学研究理事会; 英国工程与自然科学研究理事会;
关键词
Medical test; Target Product Profile; TPP; Quality by design; Diagnostic; Test characteristic; BIOMARKER; LANDSCAPE; ACCURACY;
D O I
10.1186/s12916-020-01582-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundA Target Product Profile (TPP) outlines the necessary characteristics of an innovative product to address an unmet clinical need. TPPs could be used to better guide manufacturers in the development of 'fit for purpose' tests, thus increasing the likelihood that novel tests will progress from bench to bedside. However, there is currently no guidance on how to produce a TPP specifically for medical tests.MethodsA systematic review was conducted to summarise the methods currently used to develop TPPs for medical tests, the sources used to inform these recommendations and the test characteristics for which targets are made. Database and website searches were conducted in November 2018. TPPs written in English for any medical test were included. Based on an existing framework, test characteristics were clustered into commonly recognised themes.ResultsForty-four TPPs were identified, all of which focused on diagnostic tests for infectious diseases. Three core decision-making phases for developing TPPs were identified: scoping, drafting and consensus-building. Consultations with experts and the literature mostly informed the scoping and drafting of TPPs. All TPPs provided information on unmet clinical need and desirable analytical performance, and the majority specified clinical validity characteristics. Few TPPs described specifications for clinical utility, and none included cost-effectiveness.ConclusionsWe have identified a commonly used framework that could be beneficial for anyone interested in drafting a TPP for a medical test. Currently, key outcomes such as utility and cost-effectiveness are largely overlooked within TPPs though and we foresee this as an area for further improvement.
引用
收藏
页数:12
相关论文
共 69 条
[1]   Early Economic Evaluation of Diagnostic Technologies: Experiences of the NIHR Diagnostic Evidence Co-operatives [J].
Abel, Lucy ;
Shinkins, Bethany ;
Smith, Alison ;
Sutton, Andrew J. ;
Sagoo, Gurdeep S. ;
Uchegbu, Ijeoma ;
Allen, A. Joy ;
Graziadio, Sara ;
Moloney, Eoin ;
Yang, Yaling ;
Hall, Peter .
MEDICAL DECISION MAKING, 2019, 39 (07) :857-866
[2]  
Abuhav I., 2018, 134852016 ISO
[3]  
[Anonymous], 2009, GUID IND Q8 2 PHARM
[4]  
[Anonymous], 2017, Development of a target product profile (TPP) and a framework for evaluation for a test for predicting progression from tuberculosis infection to active disease, DOI DOI 10.1007/S00216-021-03702-Z
[5]  
[Anonymous], 2018, Bioanalytical Method Validation Guidancefor Industry
[6]  
[Anonymous], 2015, TARGET PRODUCT PROFI
[7]  
[Anonymous], 2013, PRIORITY MEDICINES E
[8]  
Association for the Advancement of Medical Instrumentation, 2013, HUM FACT ENG DES MED
[9]   Beyond Diagnostic Accuracy: The Clinical Utility of Diagnostic Tests [J].
Bossuyt, Patrick M. M. ;
Reitsma, Johannes B. ;
Linnet, Kristian ;
Moons, Karel G. M. .
CLINICAL CHEMISTRY, 2012, 58 (12) :1636-1643
[10]  
Burke W., 2007, Moving beyond ACCE: an expanded framework for genetic test evaluation